[1] |
Deng Lili, Duan Xingyu, Li Baozhong.
Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma
[J]. Journal of International Oncology, 2023, 50(12): 751-757.
|
[2] |
Xie Yu, Zheng Shengnan, Huang Mingmin, Guo Aibin, Yin Zhenyu, Lin Yongjuan.
Pemetrexed clinical trial for intrathecal injection chemotherapy based on cerebrospinal fluid pharmacokinetics in patients with leptomeningeal metastasis from lung adenocarcinoma
[J]. Journal of International Oncology, 2023, 50(10): 585-591.
|
[3] |
Lin Yongjuan, Li Huiying, Yin Zhenyu, Guo Aibin, Xie Yu.
Investigation of cerebrospinal fluid metabolites in patients with leptomeningeal metastases from lung adenocarcinoma based on untargeted metabolomics
[J]. Journal of International Oncology, 2022, 49(7): 390-399.
|
[4] |
Li Yangyi, Gong Yan, Xie Conghua.
SAMHD1 inhibits PD-L1 expression in lung adenocarcinoma cells
[J]. Journal of International Oncology, 2022, 49(11): 658-664.
|
[5] |
Wang Jun, Zhao Xia, Li Haifei, Zhang Cheng.
Clinic diagnostic value of MSCT imaging features in nodular lung adenocarcinoma subtype
[J]. Journal of International Oncology, 2021, 48(9): 537-543.
|
[6] |
Li Tiantian, Shi Licheng, Kong Hui, Qi Xu.
Research on the correlation between driver genes of lung adenocarcinoma and venous thromboembolism
[J]. Journal of International Oncology, 2021, 48(6): 370-373.
|
[7] |
Zhang Bei, Wang Ye, Hu Jun, Li Mei, Wang Jun, Mu Yunfeng, Yang Bo.
Atypical MSCT pleomorphic signs in metastatic adenocarcinoma and squamous cell carcinoma of the lung
[J]. Journal of International Oncology, 2021, 48(10): 591-595.
|
[8] |
Zhou Liya, Li Xiaoli, Cao Zixiao, Xiang Junxin, Liu Jiahui, Xia Xuemei, Li Dianming.
Clinical observation of albumin-bound paclitaxel or pemetrexed combined with cisplatin in the treatment of advanced mutation negative lung adenocarcinoma
[J]. Journal of International Oncology, 2021, 48(10): 596-601.
|
[9] |
Wang Jiali, Han Dong, Chen Ying, Zhang Yamin, Ai Meimei.
Construction of a nomogram of overall survival of patients with clear cell renal cell carcinoma based on preoperative CT findings
[J]. Journal of International Oncology, 2020, 47(8): 480-486.
|
[10] |
Hou Xiaofeng, Xue Jincai, Tian Youxin, Liu Qinjiang.
Diagnosis and surgical treatment of differentiated thyroid carcinoma in 40 years
[J]. Journal of International Oncology, 2020, 47(8): 449-456.
|
[11] |
Bu Qian, Huang Junxing.
Application of neoadjuvant therapy in the treatment of esophageal cancer
[J]. Journal of International Oncology, 2020, 47(4): 244-248.
|
[12] |
Fan Yangyang, Wang Ying, Yuan Feng, Du Shanping, He Rongrong, Jia Yan.
Study on the mechanism of MALAT1 targeting miR-142-3p in ovarian cancer chemotherapy resistance
[J]. Journal of International Oncology, 2020, 47(2): 82-89.
|
[13] |
Wang Min, Fang Haohui.
Level and clinical significance of NLR, PLR and CEA in peripheral blood of patients with lung adenocarcinoma
[J]. Journal of International Oncology, 2019, 46(4): 211-215.
|
[14] |
Hu Wei, Zhang Yu.
Analysis of gene detection status of EGFR mutation in 170 patients with advanced lung adenocarcinoma
[J]. Journal of International Oncology, 2019, 46(1): 11-16.
|
[15] |
Fan Sunfu, Wang Xinbao.
Research progress of neoadjuvant therapy in adenocarcinoma of the esophagogastric junction
[J]. Journal of International Oncology, 2016, 43(1): 53-55.
|